文献速递哮喘

循环miRNA与儿童哮喘ICS反应:维生素D效应修饰的RCT分层分析

Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification.
PubMed 文献 · Thorax · 2025-10-15

该研究基于儿童哮喘管理计划(CAMP)中187例随机接受ICS治疗的受试者,分析基线血清miRNA与4年FEV1%变化的关系并按基线维生素D水平分层。在维生素D不足者中,12个miRNA与ICS介导的FEV1%变化显著相关,11个与维生素D存在显著交互;hsa-miR-125a-5p和hsa-miR-181a-5p预测ICS反应的AUC为0.86。结论提示维生素D可能通过免疫细胞分化相关miRNA调节ICS反应。

要点

  • 维生素D不足的儿童哮喘患者中,部分循环miRNA与ICS后FEV1%变化相关。
  • hsa-miR-125a-5p与hsa-miR-181a-5p在维生素D不足组预测ICS反应AUC达0.86。
  • 11个miRNA与维生素D存在显著交互,提示维生素D可能修饰ICS反应。

核心结论

  • 维生素D可能通过参与免疫细胞分化的miRNA调节ICS反应,这些miRNA或可作为ICS反应生物标志物,尤其在维生素D不足个体中。

研究设计与样本

  • 基于儿童哮喘管理计划(CAMP)随机对照试验干预臂的分层分析,纳入187例随机接受ICS治疗的受试者。
  • 对462名CAMP受试者基线血清miRNA进行测序;对22名受试者的淋巴母细胞样B细胞系进行地塞米松、维生素D或对照处理的微阵列分析。

主要发现

  • 在维生素D不足受试者中,12个miRNA与ICS介导的FEV1%变化显著相关,11个miRNA与维生素D存在显著交互(p≤0.05)。
  • 3个miRNA在哥斯达黎加哮喘遗传学研究中得到大致重复。
  • 地塞米松和维生素D处理的LCLs分别识别出220个和240个差异表达基因。
  • hsa-miR-125a-5p、hsa-miR-181a-5p、hsa-miR-101-3p和hsa-miR-107富集于造血和白细胞分化通路(p≤0.05)。
  • hsa-miR-125a-5p和hsa-miR-181a-5p在维生素D不足组预测ICS反应AUC为0.86。

临床怎么用

  • 对维生素D不足的儿童哮喘患者,可探索检测hsa-miR-125a-5p和hsa-miR-181a-5p以辅助预测ICS反应。

局限性

  • 摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: miRNAs play a crucial role in the anti-inflammatory effects of inhaled corticosteroids (ICS) in asthma. Vitamin D can modulate the expression of several miRNAs and reduces asthma exacerbations, but its molecular interaction with ICS remains unclear. OBJECTIVE: We hypothesised that vitamin D influences long-term ICS response through miRNA regulation. METHODS: Baseline serum miRNAs were sequenced from 462 subjects in the Childhood Asthma Management Program (CAMP), with 187 randomised to ICS treatment included in this study. Linear regression assessed associations between miRNA expression and prebronchodilator forced expiratory volume in 1 s per cent predicted (FEV1%) change over 4 years, stratified by baseline vitamin D levels and tested in interaction models. Microarray analysis of lymphoblastoid B cells (lymphoblastoid cell lines (LCLs)) from 22 CAMP subjects treated with dexamethasone (DEX), vitamin D or sham identified differentially expressed genes (DEGs). An miRNA target gene network was constructed, clustered and annotated by enrichment analysis. Top miRNAs were evaluated for ICS response prediction. RESULTS: 12 miRNAs were significantly associated with ICS-mediated FEV1% change in vitamin D insufficient subjects, and 11 miRNAs showed significant interaction with vitamin D (p≤0.05). Three miRNAs were approximately replicated in the Genetics of Asthma in Costa Rica Study. Microarray analysis identified 220 and 240 DEGs in DEX and vitamin D-treated LCLs, respectively. miRNAs hsa-miR-125a-5p, hsa-miR-181a-5p, hsa-miR-101-3p and hsa-miR-107 were enriched in haemopoiesis and leucocyte differentiation pathways (p≤0.05). Two miRNAs, hsa-miR-125a-5p and hsa-miR-181a-5p, predicted ICS response with an area under the receiver operating characteristic curve of 0.86 in the vitamin D insufficient group. CONCLUSIONS: Vitamin D may modulate ICS response through miRNAs involved in immune cell differentiation, which could serve as biomarkers for ICS response, particularly in vitamin D insufficient individuals.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Jiang M, Zhang Y, Liu T, et al. Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification. Thorax. 2025. PMID: 40467329. doi:10.1136/thorax-2024-222618

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。